Investor Presentaiton

East Africa Kenya market 2013 circa 642M USD - Patented drugs = 9% Generic drugs = 63% - OTC = 28% Kenya comprises circa 80% of regional volumes = 18% Exports (Tanzania, Uganda, Sudan and Somalia) CAGR = Untapped sales in adjacent countries - Limited distributor funding - Stock outs - Lead times Uganda growth estimated at 27% Ethiopia generic growth with Chinese partnerships IMPERIAL HEALTH SCIENCES TM

View entire presentation